SMi proudly presents its 12th annual Pain Therapeutics conference.Pain is the most common reason patients seek medical care and has significant sensory and emotional components. Despite the advances in pain management, few significant advancements have been made, and in recent years it has become harder and harder to get analgesics to market.With the whole industry under financial pressure, there is an economic imperative for companies to improve their research and development methods in order to ensure that drugs being put forward for clinical trials have the best chance of success.Pain Therapeutics 2012 will allow delegates to hear from industry experts discussing the latest advances in drug development practice and analysing recent case studies of where drugs in the clinical stages have succeeded and failed. This must-attend event will also take an in-depth look at the recent work on current drug targets such as the TRPV family, the Opioid family and Nerve Growth Factor. Hear key presentations from industry-leading experts:Kevin Lee, Head of Epigenetics Discovery Unit, Epinova (GlaxoSmithKline)Chas Bountra, Professor of Translational Medicine, Head, Structural Genomics Centre Oxford UniversityJohnathan Stewart, Disease Area Head, Neuroscience, Immunology and Pain, Bristol-Myers SquibbPhilip Kym, Associate Director II Pain Discovery Research, AbbottMark Bowlby, Neurophysiology and Pain Lead, MerckSteven England, Associate Director R&D, AstraZenecaDave Shelton, Senior Director, Pfizer Global Research & DevelopmentJaymin Upadhyay, Senior Scientist II Translational Sciences, Abbott Laboratories  BOOKING INFORMATIONVisit our website for more information.Alternatively, contact Ninica Hussain: +44 (0)207 827 6115 SPONSORSHIP & EXHIBITION OPPORTUNITIESSMi Group offers direct access to key decision makers in this sector through tailored sponsorship and exhibitor packagesFor details contact Alia Malick: +44 (0)207 827 6168